Skip to main content
HeartCited

NMN (Nicotinamide Mononucleotide) के लिए Heart Failure

D

Preclinical data shows NAD+ restoration may support cardiac function in animal heart failure models. No human heart failure trials yet. Mechanism through SIRT1 activation and mitochondrial biogenesis.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dnmn\u0026condition\u003Dheart\u002Dfailure'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  




    








    

        

            D

        

        

            
निष्कर्ष

            
            
Preclinical data shows NAD+ restoration may support cardiac function in animal heart failure models. No human heart failure trials yet. Mechanism through SIRT1 activation and mitochondrial biogenesis.

            
            
        

    











    
    

        
        

            

  
Key Statistics





            


    

        
0

        
अध्ययन

    

    

        
--

        
प्रतिभागी

    

    

        
            
            ↑
            
        
        
Positive

    

    

        D

        
ग्रेड

    




        


        
        

        
        
        

            

  
Dosage & Usage





            
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units


            
            

                
सामान्य रूप से उपयोग की जाने वाली खुराकें

                

                    
                    

                        
general:

                        
250-500 mg/day

                    

                    
                    

                        
antiagingprotocols:

                        
500-1,000 mg/day

                    

                    
                

                
                

                    अधिकतम सीमा: Not formally established; up to 1,200 mg/day used in human trials without significant adverse e
                

                
            

            

            

            
            

                सेवन का सर्वोत्तम समय: Morning on empty stomach or with light meal; sublingual for enhanced bioavailability
            

            
        

        

        
        
        

            

  
Safety & Side Effects





            

                
                

                    
रिपोर्ट किए गए दुष्प्रभाव

                    
    
                        
                        
  • 
                            ⚠
                            Generally well-tolerated
                        
    • 
                        
                        
  • 
                            ⚠
                            Mild gastrointestinal discomfort
                        
    • 
                        
                        
  • 
                            ⚠
                            Flushing (rare)
                        
    • 
                        
                        
  • 
                            ⚠
                            Headache (rare)
                        
    • 
                        
                    

                

                

                
                

                    
ज्ञात अंतःक्रियाएँ

                    
    
                        
                        
  • 
                            ●
                            May interact with NAD+-dependent medications
                        
    • 
                        
                        
  • 
                            ●
                            Theoretical interaction with diabetes medications (may affect glucose metabolism)
                        
    • 
                        
                    

                

                

                
                

                    

                        सहनीय अधिकतम सेवन: Not formally established; up to 1,200 mg/day used in human trials without significant adverse e
                    

                

                
            

            

                कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।
            

        

        

        
        
        

            

  
Frequently Asked Questions





            




    
    

        
            Does NMN (Nicotinamide Mononucleotide) help with Heart Failure?
            
        
        

            Based on 0 studies with 0 participants, there is preliminary evidence that needs more research that NMN (Nicotinamide Mononucleotide) may support Heart Failure management. Our evidence grade is D (Very Early Research).
        

    

    
    

        
            How much NMN (Nicotinamide Mononucleotide) should I take for Heart Failure?
            
        
        

            Studies have used various dosages. A commonly studied range is 250-500 mg/day. Always consult your healthcare provider before starting any supplement regimen.
        

    

    
    

        
            Are there side effects of NMN (Nicotinamide Mononucleotide)?
            
        
        

            Reported side effects may include Generally well-tolerated, Mild gastrointestinal discomfort, Flushing (rare), Headache (rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
        

    

    
    

        
            How strong is the evidence for NMN (Nicotinamide Mononucleotide) and Heart Failure?
            
        
        

            We rate the evidence as Grade D (Very Early Research). This rating is based on 0 peer-reviewed studies with 0 total participants. The overall direction of effect is positive.
        

    

    




        

        

        
        
        

            

  
Related Evidence





            

                
                
                

                
                

                    
NMN (Nicotinamide Mononucleotide) अन्य स्वास्थ्य स्थितियों के लिए

                    

                        
                        
                            Arterial Stiffness
                            C

                        
                        
                    

                

                
            

        

        

    


    
    












    

        FDA अस्वीकरण:
        इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।